Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi
02 1ORIFARM GROUP AS
03 1SHIRE PLC
04 10Takeda Pharmaceutical
01 2Concentrate For Infusion Solution
02 7Concentrate For Solution For Infusion
03 1INF
04 1Infusion Concentrate
05 2POI
06 2POWDER FOR SOLUTION
07 2Powder For Concentrate For Infusion Solution
08 2Powder For Concentrate For Solution For Infusion
09 1SOLUTION
10 2VIAL; INTRAVENOUS
01 1Allowed
02 1Approved
03 4Authorized
04 1Marketed
05 3Not Marketed
06 3Originator
07 5Prescription
08 2Schedule D
09 2Blank
01 4FABRAZYME
02 4Fabrazyme
03 1Fabrazyme 35mg
04 1Fabrazyme 5mg
05 1REPLAGAL
06 10Replagal
07 1Replagal Durchstechflasche
01 3Canada
02 3Denmark
03 1Estonia
04 4Norway
05 3South Africa
06 4Spain
07 1Sweden
08 1Switzerland
09 2USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : FABRAZYME
Dosage Form : VIAL; INTRAVENOUS
Dosage Strength : 5MG/VIAL
Packaging :
Approval Date :
Application Number : 103979
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : FABRAZYME
Dosage Form : VIAL; INTRAVENOUS
Dosage Strength : 35MG/VIAL
Packaging :
Approval Date :
Application Number : 103979
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Fabrazyme
Dosage Form : Powder For Concentrate For Infusion Solution
Dosage Strength : 5MG
Packaging :
Approval Date : 13-01-2004
Application Number : 1188004
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Fabrazyme
Dosage Form : Powder For Concentrate For Infusion Solution
Dosage Strength : 35MG
Packaging :
Approval Date : 31-08-2001
Application Number : 1188001
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : FABRAZYME
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 5MG/VIAL
Packaging : 1.1ML
Approval Date :
Application Number : 2248965
Regulatory Info : Prescription
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : FABRAZYME
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 35MG/VIAL
Packaging : 7.2ML
Approval Date :
Application Number : 2248966
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fabrazyme 35mg
Dosage Form : POI
Dosage Strength : 35mg/20ml
Packaging : 20X1mg/20ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fabrazyme 5mg
Dosage Form : POI
Dosage Strength : 5mg/5ml
Packaging : 5X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fabrazyme
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 35mg
Packaging :
Approval Date : 03-08-2001
Application Number : 28103161500
Regulatory Info : Prescription
Registration Country : Denmark
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Fabrazyme
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 5mg
Packaging :
Approval Date : 02-12-2002
Application Number : 28103735602
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Not Marketed
Registration Country : Norway
Brand Name : Replagal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Replagal
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 1MG
Packaging :
Approval Date : 20-05-2005
Application Number : 1189004
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Replagal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1mg/ml
Packaging :
Approval Date : 2001-08-03
Application Number : 20010803000019
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Replagal Durchstechflasche
Dosage Form : Infusion Concentrate
Dosage Strength : 1mg/ml
Packaging :
Approval Date : 28/12/2001
Application Number : 55774
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Not Marketed
Registration Country : Norway
Brand Name : Replagal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Not Marketed
Registration Country : Norway
Brand Name : Replagal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Replagal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Replagal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Replagal
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 1MG
Packaging :
Approval Date : 11-02-2002
Application Number : 1189001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : REPLAGAL
Dosage Form : SOLUTION
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number : 2249057
Regulatory Info : Schedule D
Registration Country : Canada
